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Epidemiological studies rarely provide unequivocal data on the effects of toxic substances on human
health. Unlike experimental studies, pertinent variables frequently cannot be controlled and some are
often unknown. Nevertheless, these limitations can be dealt with by various facets ofan epidemiological
investigation. These include, the choice ofastudy design, selection ofcontrols or comparison populations,
evaluation ofavailable data, statistical analysis, andthe drawingofappropriate inferences from the data.
Among the special problems that might beencountered in studiesoftheeffectsofcardiotoxic substances
are, difficulties in establishing diagnoses, errors in death certificates, observer errors in electrocardio-
graphic interpretations, and taking into account the effects ofvarious risk factors known to be implicated
intheetiologyofcardiovascular diseases.
In spite ofvarious methodological problems and certain inherent limitations ofepidemiological studies,
they can, when properly conducted, make significant contributions to knowledge ofdisease etiology and
provide the means of reducing the risk of a disease, even when its etiology is not completely known.
When aparticular chemical compound isfound to
be toxic to animals, data on the nature and extent of
that chemical's toxicity to humans are frequently
sought in an epidemiological investigation.
At the outset, it should be understood that an
epidemiological study rarely provides definitive,
unequivocal answers to questions concerning the
effects oftoxic substances on the health ofhumans.
Data derived from the study usually permit the in-
vestigatorto draw only carefully guarded inferences
concerning causal relationships between the sub-
stance and health impairments observed in an ex-
posed population.
In contrast to animal experimentation, human
studies usually cannot provide adequate control of
confounding variables. Subjects cannot be assigned
at random to an exposed and control group, en-
vironmental conditions cannot be controlled, diets
cannot be standardized, and genetic factors cannot
be controlled by the use of purebred strains.
The ideal human study would be one in which the
exposed and control groups are comparable with
respect to all characteristics related to the diseases
under investigation except that one group is or has
been exposed to the toxic substance and the other
has never been exposed. This ideal can rarely, if
ever, be attained.
The task ofthe epidemiologist is to apply various
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strategies and statistical techniques in such ways
that he or she will come as close to achieving that
ideal as the available information will allow. That
task includes the following facets of an
epidemiological study: study design, selection of
control groups or comparison populations, evalua-
tion of the quality of available data, statistical
analyses, and the drawing ofappropriate inferences
from the data. I shall discuss each ofthese briefly.
Study Design
Epidemiologists do not entirely agree on the ter-
minology forthe classification ofstudy designs. The
terms I shall use here are those that have been
adopted by MacMahon and Pugh (1).
The two basic types of epidemiological studies
are cohort and case-control studies. In a cohort
study, a study population is followed over a
specified period of time to compare disease rates
among those in the population having a characteris-
tic with persons who do not have the characteristic.
Comparisons can also be made with general popula-
tion. It is important that at the beginning of the
study period all members of the cohort are free of
the disease under investigation. To study, for
example, the relation of exposure to a certain
chemical compound to the development ofcoronary
heart disease, one would identify cohorts of ex-
posed and ofnonexposed persons, allfree ofclinical
coronary heart disease, and then identify those
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the disease.
Cohort studies may be either retrospective or
prospective. In a retrospective study, the cohort is
identified as of some time in the past and followed
to a later date. In a prospective study, the cohort is
established in the present and followed into the fu-
ture. Retrospective cohort studies have also been
described as historical prospective studies (2).
In a case-control study, a group of persons who
have the disease is compared with a group free of
the disease (the control group) to determine
whether a given characteristic is more common
among persons with the disease. In the example
cited above, one would select a group of persons
known to have coronary heart disease and a control
group of persons free of the disease. Then the two
groups would be compared with respect to the pro-
portion in each group that has been exposed to the
compound.
Cohort studies-especially prospective cohort
studies-are preferable to case-control studies. The
data from cohort studies provide direct measures of
the risk of disease in exposed and nonexposed
populations, whereas case-control studies would
yield only estimates of risk, sometimes crude, im-
precise estimates. Cohort studies, on the other
hand, require a larger numberofsubjects and along
follow-up period. Ifthe disease is rare, it may not be
practicable to assemble the large sample size re-
quired in a cohort study. The case-control study has
among its advantages the requirement of a com-
paratively small number of subjects and the short
period of time in which results can be obtained.
One other study design that should be mentioned
is the cross-sectional study. The data obtained in
this type of study are gathered as they exist at a
specific point in time. The study population is sur-
veyed to identify those who have a particular dis-
ease or diseases. Then, the prevalence ofdisease is
analyzed in relation to pertinent characteristics of
that population.
It is tempting to use this study design because
such a study makes use of existing data, or of data
that can be developed in a short period oftime, and
therefore results can be obtained much sooner than
in a cohort study. Cross-sectional studies, however,
do have important drawbacks, particularly in
studies of the relation of cardiovascular disease to
exposure to toxic chemicals.
One important problem arises out ofthe high case
fatality rate and the reduced survival time found in
cardiovascular disease. Since a cross-sectional
study would enumerate only living cases, failure to
include those who died before the study was un-
dertaken may seriously bias the results. If, for
example, a particular chemical causes a sudden
cardiac death, or ifsurvival time following the onset
ofthe episode is short, most, ifnot all those affected
by the chemical would not be enumerated in a
cross-sectional study, and, as a result, the study
would fail to reveal a cardiotoxic effect.
Another problem in a cross-sectional study is the
difficulty in determining the temporal relation be-
tween first exposure to the substance and the onset
ofthe disease. The former must precede the latter if
there is a causal relation. Furthermore, the time
interval between exposure and disease onset must
be known to determine ifthere is a latent effect and
the length of the latent period. These kinds of data
are usually not available in cross-sectional studies.
Each study design has its merits and limitations.
The choice depends upon an assessment of the
available data, which design is most appropriate for
the data, and a careful weighing of the advantages
and disadvantages of each type of study.
Selection of Controls
The choice ofthe propercontrolgroup is acrucial
element in an epidemiological study. It is by this
choice that the investigator can take into account
factors other than exposure to the chemical that are
related to the disease. In a case-control study, for
example, one control can be selected for each case
so that the case and control are matched by such
factors as age, sex, and race. In cohort studies,
where matching is usually not feasible, the control
group may consist ofworkers at the plant who have
no history ofexposure to the chemical. In this case,
confounding variables can be taken into account by
statistical analysis.
In cohort mortality studies, investigators fre-
quently compare mortality in the exposed group
with death rates in the U. S. population or in sub-
divisions ofthe U. S., such as the state or county in
which the plant is located. It has been well estab-
lished, however, that mortality in working popula-
tions is generally lower than in the general popula-
tion because of selection factors that tend to
exclude from the work force persons who are
chronically ill (3-5). Mortality in the U. S. has been
used for comparative purposes because data for
employed persons have not been readily available.
If one must use the U. S. as a comparison popula-
tion, an assessment of differences between the
U. S. and the exposed cohort must take into ac-
count the lower death rates normally found in
working populations, especially among younger
persons. In acomparison ofdeath rates between the
Du Pont Company and the U. S. we found that the
ratio of death rates (Du Pont/U. S.), adjusted for
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ease it was 0.82, and for cerebrovascular disease,
0.99 (6). Morbidity from acute myocardial infarction
in the Du Pont population, however, differed little
from that found in other surveyed populations (7).
Evaluation of Available Data
If the raw data available for a study are deficient
with respect to their reliability, validity, and com-
pleteness, the results will be oflittle value, no mat-
ter how well the study is designed and no matter
how sophisticated the statistical analysis may be.
There are certain problems in the diagnoses of
cardiovascular diseases that have to be dealt with in
epidemiological studies. One is the occurrence of
asymptomatic disease, such as a "silent" myocar-
dial infarction, i.e., where the individual was not
aware of, or did not report, symptoms, but evidence
of myocardial damage appears on the electrocar-
diogram.
Anotherproblem is how to deal with symptoms of
cardiovascular diseases in the absence of objective
evidence of disease. One example is chest pain on
exertion, suggesting angina pectoris, but where the
electrocardiogram is normal. Another example is
the occurrence of a syndrome, such as, dizziness,
weakness, and loss of muscular coordination,
suggesting cerebrovascular disease, but with no
otherinformation to establish adefinitive diagnosis.
The electrocardiogram is a means of obtaining
objective evidence of heart disease, but although
the measurements produced by the electrocardio-
gram are objective, their interpretation is not.
Studies of the reproducibility of electrocardio-
graphic interpretations have shown a significant
amount of disagreement among observers and be-
tween repeated interpretations made by the same
observer (8, 9). Although the electrocardiogram is,
nevertheless, an important diagnostic tool for heart
diseases, problems in its interpretation must be
taken into account when it is used in epidemiologi-
cal studies.
The use ofdeath certificate information in studies
ofcardiovascular diseases presents us with another
major problem. Errors in statements of cause of
death are common. One source oferror arises when
there is a sudden, unattended death, and no autopsy
is performed. A common practice is to attribute the
death to a heart attack. The magnitude ofdeath cer-
tificate errors has been studied where autopsy data
were available. One such study by Beadenkopf et
al. found that "in only 50 percent ofthe individuals
with infarction or coronary thrombosis at autopsy
was arteriosclerotic heart disease coded on the
death certificate" (10). They also found, however,
that "82 percent of the death certificates reporting
arteriosclerotic heart disease as the cause of death
were confirmed as cases by autopsy findings."
In enumerating the occurrence of a particular
type of cardiovascular disease in a cohort, all the
problems discussed above must be taken into ac-
count. It is important thatrigid diagnostic criteriabe
established and that all members ofthe cohort who
develop the disease according to these criteria be
identified. Failure to meet these requirements can
result in misclassification of diseased and non-
diseased persons and in biases in the data that can
result in misleading conclusions. Such deficiencies
in the data are apt to be found in a retrospective,
rather than a prospective, cohort study, where the
investigator must rely on data developed in the past
and generated in such a way that they do not meet
the rigid requirements ofan epidemiological study.
Another problem arises in the identification of
exposed persons. Work histories must be adequate
to identify all persons with a history of exposure in
the surveyed population, and, wherever possible, to
furnish data on the level and duration of exposure.
Biases can result if a certain segment of exposed
persons is not identified and thereby not included in
the cohort.
Statistical Analysis
In its simplest form, the statistical analysis of
epidemiological data consists of computing an inci-
dence rate or death rate in an exposed and control
group, computing the ratio ofthe two rates to obtain
a measure of relative risk, and then performing a
test ofsignificance to decide whether the difference
could have occurred by chance alone, or whether
the difference is probably real.
Usually, however, epidemiological data require
more complex statistical analyses. Time does not
permit an even cursory outline of all the analytical
problems that arise in epidemiological data and how
those problems are dealt with by various statistical
techniques, but I would like to discuss briefly one
major problem in occupational health studies, and
that is the need to sort out the various factors re-
lated to the disease in order to determine to what
extent, if any, the substance under investigation in-
creases the risk of the disease among exposed
workers.
It is well known that all diseases, particularly
cardiovascular diseases, have a multiple etiology.
Whether a particular individual will develop a given
disease depends upon the influence of the three
major components involved in the etiology of dis-
ease: the agent, the host, and the environment.
Fortunately, we know a great deal about the
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thanks to several epidemiological studies-notably
the Framingham Heart Study-that have been con-
ducted in the past 25 years. These studies have
identified risk factors for coronary heart disease,
stroke, and hypertension. In addition, the data gen-
erated by these studies have been utilized to mea-
sure the extent to which the variousfactors increase
risk, either alone or in combination. For coronary
heart disease, these studies have identified three
major risk factors: elevated serum cholesterol,
hypertension, and cigarette smoking, as well as
other risk factors, such as diabetes mellitus, over-
weight, sedentary living, personality factors, and
family history of coronary heart disease (11). If a
study is undertaken to investigate the possible role
of a particular chemical compound in the develop-
ment ofcoronary heart disease, data on the known
risk factors would have to be taken into account in
order to isolate the effect of the chemical.
The various statistical methods that have been
applied to achieve this objective come under the
general category of multiple regression analysis.
One especially useful technique has been the multi-
ple logistic function (12). By this method, one can
identify significant risk factors and measure the
contribution to risk made by each factor, relative to
the contribution of other risk factors.
Drawing Inferences from the
Results
A fundamental question that arises out of
epidemiological data is whether aparticular statisti-
cal association indicates a causal relationship. If,
for example, the death rate from a coronary heart
disease is found to be significantly greater among
workers exposed to a given chemical than among
those in a nonexposed control group, can one con-
clude that the chemical was responsible for the in-
creased death rate?
Thatconclusion can be drawn ifallfactors related
to coronary heart disease were known and taken
into account by the design of the study and/or the
statistical analysis. It is rare that such an objective
can be achieved in an epidemiological study. Al-
though we have learned a great deal about risk fac-
tors for the major cardiovascular diseases, the
etiology ofthese diseases is still not completely un-
derstood. Other risk factors remain to be identified.
Moreover, in many epidemiological studies
especially when they are retrospective-it is not al-
ways possible to obtain all relevant information.
Therefore, in almost all studies, there usually re-
mains some doubt about the meaning ofthe statisti-
cal relationships.
In drawing inferences from the results of the
study, one must do so by making a careful assess-
ment of various aspects of the data to determine
whether they tend to strengthen the hypothesis ofa
causal relationship orlend little or no support to the
hypothesis. Among the factors that have to be con-
sidered are the following: the adequacy ofthe study
design; the reliability and validity of the data; the
extent of missing relevant data; the degree of the
statistical association, as measured by such statis-
tics as the relative risk, odds ratio, and correlation
coefficient (the greater the degree of association,
the more likely the association indicates a causal
relationship); the dose-response relationship (the
existence ofsuch arelationship strengthens acausal
hypothesis); whether or not the relationship be-
tween the substance and the disease can be ex-
plained by a biological mechanism; and whether or
not the results of the study are consistent with the
findings ofother studies.
Conclusions
This discussion ofthe epidemiologic approach to
the study of toxic substances has necessarily
touched only briefly on methodology, statistical
techniques, and problems in the interpretation of
epidemiologic data. Because of the brevity of the
discussion, portions ofit may have been somewhat
oversimplified.
The purpose of this paper, however, has been
primarily to describe the rationale of the
epidemiologic approach and to point out certain
limitations of epidemiological data. One should
keep in mind that, in spite of their limitations,
epidemiological studies have contributed greatly to
an understanding of the etiology of many diseases,
and have also provided us with the capability of
instituting preventive measures to reduce the risk of
various diseases, even when their etiology is not
completely known.
REFERENCES
1. MacMahon, B., and Pugh, T. F. Epidemiology-Principles
and Methods, Little, Brown and Co., Boston, 1970, p. 40.
2. Mausner, J. S., and Bahn, A. K. Epidemiology-An Intro-
ductory Text, Saunders, Philadelphia, 1974, p. 325.
3. Enterline, P. E. The estimation ofexpected rates in occupa-
tional disease epidemiology. PubI. Health Repts. 79: 973
(1964).
4. Redmond, C. K., and Breslin, P. P. Comparison ofmethods
for assessing occupational hazards, J. Occup. Med. 17: 313
(1975).
5. McMichael, A. J. Standardized mortality ratios and the
"healthy worker effect:" scratching beneath the surface. J.
Occup. Med. 18: 165 (1976).
6. Pell, S. The effect of selection factors on epidemiologic re-
search in employed populations. In: The Nature of Bio-
statistics. University ofPittsburgh, Pittsburgh, 1969, p. 175.
272 Environmental Health Perspectives7. Shapiro, S., et al. Incidence of coronary heart disease in a
population insured for medical care (HIP). Amer. J. Publ.
Health59(Suppl.): 12 (1969).
8. Acheson, R. M. Observer error and variation in the in-
terpretation of electrocardiograms in an epidemiological
study ofcoronary heart disease. Brit. J. Prev. Soc. Med. 14:
99 (1960).
9. Higgins, I. T. T., Kannel, W. B., and Dawber, T. R. The
electrocardiogram in epidemiological studies-re-
producibility, validity, and international comparison. Brit. J.
Prev. Soc. Med. 19: 53 (1965).
10. Beadenkopf, W. G., et al. An assessment ofcertain medical
aspects of death certificate data for epidemiologic study of
arteriosclerotic heart disease. J. Chron. Dis. 16: 249 (1963).
11. Simborg, D. W. The status ofrisk factors and coronary heart
disease. J. Chron. Dis. 22: 515 (1970).
12. Truett, J., Cornfield, J., and Kannel, W. B. A multivariate
analysis ofthe risk ofcoronary heart disease in Framingham,
J. Chron. Dis. 20: 511 (1967).
October 1978 273